R
ReNAgade Therapeutics
Cambridge, United States
Founded 2021
About
RNA delivery technology for extrahepatic targets
Company Details
- Type
- commercial
- Employees
- 100-200
- Funding
- $300M+
Key Products
- Tissue-Selective RNA Delivery
RNA delivery technology for extrahepatic targets